NEW YORK – A new study from an international group of researchers has found that a portion of patients with life-threatening COVID-19 pneumonia carry mutations affecting the type I interferon (IFN) pathway, explaining the severity of their symptoms.
NEW YORK – A new study from an international group of researchers has found that a portion of patients with life-threatening COVID-19 pneumonia carry mutations affecting the type I interferon (IFN) pathway, explaining the severity of their symptoms.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.